Market size, growth to 2033 and clinical trials, side by side.
China is the bigger Iron Supplement market: $161 Mn against $36 Mn in 2023, about 4.4 times as large.
India grows faster: 9.5% a year, against 8%. The gap still grows from $124 Mn to $257 Mn by 2033.
Clinical research: 27 active trials in China, 3 in India.
| Measure | ||
|---|---|---|
| Market size, 2023 | $161 Mn | $36 Mn |
| Market size, 2033 projected | $347 Mn | $90 Mn |
| Growth a year (CAGR) | 8% | 9.5% |
| Money added, 2023–2033 | $186 Mn | $54 Mn |
| Share of the world market | 8% | 1.8% |
| Size rank of 24 countries | #2 | #12 |
| Market per person, 2023 | $0.11 | $0.02 |
| Active clinical trials | 27 | 3 |
| Anaemia in women 15–49 % of women (WHO) | 15.6 2023 | 53.7 2023 |
| Full report | China report | India report |
China India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
China is the bigger Iron Supplement market: $161 Mn against $36 Mn in 2023, about 4.4 times as large.
India grows faster: 9.5% a year, against 8%. The gap still grows from $124 Mn to $257 Mn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Health figures: WHO. Population: World Bank.